Literature DB >> 34326477

Dynamic activity of interpeduncular nucleus GABAergic neurons controls expression of nicotine withdrawal in male mice.

Paul M Klenowski1, Rubing Zhao-Shea2, Timothy G Freels2, Susanna Molas2, Andrew R Tapper3.   

Abstract

A critical brain area implicated in nicotine dependence is the interpeduncular nucleus (IPN) located in the ventral midbrain and consisting primarily of GABAergic neurons. Previous studies indicate that IPN GABAergic neurons contribute to expression of somatic symptoms of nicotine withdrawal; however, whether IPN neurons are dynamically regulated during withdrawal in vivo and how this may contribute to both somatic and affective withdrawal behavior is unknown. To bridge this gap in knowledge, we expressed GCaMP in IPN GABAergic neurons and used in vivo fiber photometry to record changes in fluorescence, as a proxy for neuronal activity, in male mice during nicotine withdrawal. Mecamylamine-precipitated withdrawal significantly increased activity of IPN GABAergic neurons in nicotine-dependent, but not nicotine-naive mice. Analysis of GCaMP signals time-locked with somatic symptoms including grooming and scratching revealed reduced IPN GABAergic activity during these behaviors, specifically in mice undergoing withdrawal. In the elevated plus maze, used to measure anxiety-like behavior, an affective withdrawal symptom, IPN GABAergic neuron activity was increased during open-arm versus closed-arm exploration in nicotine-withdrawn, but not non-withdrawn mice. Optogenetic silencing IPN GABAergic neurons during withdrawal significantly reduced withdrawal-induced increases in somatic behavior and increased open-arm exploration. Together, our data indicate that IPN GABAergic neurons are dynamically regulated during nicotine withdrawal, leading to increased anxiety-like symptoms and somatic behavior, which inherently decrease IPN GABAergic neuron activity as a withdrawal-coping mechanism. These results provide a neuronal basis underlying the role of the IPN in the expression of somatic and affective behaviors of nicotine withdrawal.
© 2021. The Author(s), under exclusive licence to American College of Neuropsychopharmacology.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34326477      PMCID: PMC8782840          DOI: 10.1038/s41386-021-01107-1

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  42 in total

1.  Chronic nicotine cell specifically upregulates functional alpha 4* nicotinic receptors: basis for both tolerance in midbrain and enhanced long-term potentiation in perforant path.

Authors:  Raad Nashmi; Cheng Xiao; Purnima Deshpande; Sheri McKinney; Sharon R Grady; Paul Whiteaker; Qi Huang; Tristan McClure-Begley; Jon M Lindstrom; Cesar Labarca; Allan C Collins; Michael J Marks; Henry A Lester
Journal:  J Neurosci       Date:  2007-08-01       Impact factor: 6.167

Review 2.  Nicotine withdrawal.

Authors:  Ian McLaughlin; John A Dani; Mariella De Biasi
Journal:  Curr Top Behav Neurosci       Date:  2015

Review 3.  Nicotine aversion: Neurobiological mechanisms and relevance to tobacco dependence vulnerability.

Authors:  Christie D Fowler; Paul J Kenny
Journal:  Neuropharmacology       Date:  2013-09-18       Impact factor: 5.250

4.  Aversion to nicotine is regulated by the balanced activity of β4 and α5 nicotinic receptor subunits in the medial habenula.

Authors:  Silke Frahm; Marta A Slimak; Leiron Ferrarese; Julio Santos-Torres; Beatriz Antolin-Fontes; Sebastian Auer; Sergey Filkin; Stéphanie Pons; Jean-Fred Fontaine; Victor Tsetlin; Uwe Maskos; Inés Ibañez-Tallon
Journal:  Neuron       Date:  2011-05-12       Impact factor: 17.173

Review 5.  The habenulo-interpeduncular pathway in nicotine aversion and withdrawal.

Authors:  Beatriz Antolin-Fontes; Jessica L Ables; Andreas Görlich; Inés Ibañez-Tallon
Journal:  Neuropharmacology       Date:  2014-12-02       Impact factor: 5.250

6.  21st-century hazards of smoking and benefits of cessation in the United States.

Authors:  Prabhat Jha; Chinthanie Ramasundarahettige; Victoria Landsman; Brian Rostron; Michael Thun; Robert N Anderson; Tim McAfee; Richard Peto
Journal:  N Engl J Med       Date:  2013-01-24       Impact factor: 91.245

7.  Nicotinic receptor contributions to smoking: insights from human studies and animal models.

Authors:  Darlene H Brunzell; Alexandra M Stafford; Claire I Dixon
Journal:  Curr Addict Rep       Date:  2015-03

8.  Role of β4* Nicotinic Acetylcholine Receptors in the Habenulo-Interpeduncular Pathway in Nicotine Reinforcement in Mice.

Authors:  Lauriane Harrington; Xavier Viñals; Andrea Herrera-Solís; Africa Flores; Carole Morel; Stefania Tolu; Philippe Faure; Rafael Maldonado; Uwe Maskos; Patricia Robledo
Journal:  Neuropsychopharmacology       Date:  2015-11-20       Impact factor: 7.853

9.  Habenular α5 nicotinic receptor subunit signalling controls nicotine intake.

Authors:  Christie D Fowler; Qun Lu; Paul M Johnson; Michael J Marks; Paul J Kenny
Journal:  Nature       Date:  2011-01-30       Impact factor: 49.962

Review 10.  Current advances in research in treatment and recovery: Nicotine addiction.

Authors:  Judith J Prochaska; Neal L Benowitz
Journal:  Sci Adv       Date:  2019-10-16       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.